ALAB
Astera Labs, Inc. Common Stock
ALAB has a slight edge over SNDK overall, supported by lower modeled downside and stronger modeled upside.
SNDK
Sandisk Corporation
SNDK's outlook is improving, though it still trails on the overall score.
ALAB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
ALAB's revenue, profitability, cash flow and balance sheet are all currently strong.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
ALAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $228 | — |
| Cheap | 72x | $182 | -20% |
| Current | 91x | $228 | — |
| Fair | 108x | $272 | +19% |
| Expensive | 172x | $431 | +89% |
Historical ranges are pointers, not guarantees.
ALAB's PE is in its fair range at 91x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over ALAB in the historical PE scenario, which offers more potential upside but is not a forecast.
ALAB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for ALAB, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
ALAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.88 | +174% |
| Q3 2026 | $2.51 | +14% |
| Q2 2026 | $2.02 | +22% |
| Q1 2026 | $1.48 | +13% |
| Q4 2025 | $1.22 | +$1.86 |
| Q3 2025 | $2.20 | +$3.98 |
| Q2 2025 | $1.65 | +$3.40 |
| Q1 2025 | $1.31 | +$3.16 |
| Q4 2024 | -$0.64 | -$0.43 |
ALAB earned $2.51 per share over the past year, up 14% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over ALAB in the latest year-over-year earnings comparison.
ALAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $584.9M | +154% |
| Q2 2026 | $392.4M | +104% |
| Q1 2026 | $308.4M | +93% |
| Q4 2025 | $270.6M | +92% |
| Q3 2025 | $230.6M | +104% |
| Q2 2025 | $191.9M | +150% |
| Q1 2025 | $159.4M | +144% |
| Q4 2024 | $141.1M | +179% |
ALAB has the edge over SNDK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +6.6 points |
| Q2 2026 | 23% | +2 points |
| Q1 2026 | 20% | +13 points |
| Q4 2025 | 25% | +25 points |
| Q3 2025 | 24% | +32 points |
| Q2 2025 | 21% | +52 points |
| Q1 2025 | 7.1% | +134 points |
| Q4 2024 | 0.1% | -18 points |
ALAB's operating margin was 31% last quarter, up 6.6 points from the same quarter a year ago, near the top of its range since 2022.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over ALAB on profitability, with a higher operating margin.
ALAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133.9M | +103% |
| Q2 2026 | $67.2M | -50% |
| Q1 2026 | $67M | +1023% |
| Q4 2025 | $76.6M | +216% |
| Q3 2025 | $65.9M | +41% |
| Q2 2025 | $133.3M | +328% |
| Q1 2025 | $6M | +2516% |
| Q4 2024 | $24.3M | +81% |
ALAB generated $345M in free cash flow over the past year, up 50% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
ALAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +737K shares |
| 1 year | +1.9% | +3.4M shares |
| 3 years | +21% | +31.6M shares |
ALAB has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $210,000 |
| Q3 2023 | — |
| Q2 2023 | $118,000 |
| Q1 2023 | — |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ALAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -3.5x | Net Cash |
ALAB has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
ALAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 12.4 | Oversold |
ALAB's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
ALAB PE vs Technology Sector
| Metric | ALAB | Sector median | Relative |
|---|---|---|---|
| PE | 91x | 28x | 226% above |
| PE % | 33 | 17 | 16 pts above |
ALAB is trading at 91x earnings, a 226% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over ALAB on valuation relative to its sector.
ALAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $284.7 | 20% below |
| 20 week MA | $306.9 | 26% below |
| 50 week MA | $241.4 | 5.6% below |
| 100 week MA | $182.7 | 25% above |
ALAB has stronger trend alignment. ALAB is above 1 of 4 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
ALAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $70.0 | $141.5 | +102% |
| 2025 | $141.5 | $167.3 | +18% |
| 2026 YTD | $167.3 | $227.8 | +36% |
ALAB has finished every year since 2024 higher, and it's up 36% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over ALAB on returns for 2026, with the stronger performance.